It’s time for the final episode of JHLT: The Podcast for 2021! Join Daniel R. Goldstein, MD, Editor-in-Chief of JHLT, and the JHLT Digital Media Editors for two interviews with authors from the December issue of The Journal of Heart and Lung Transplantation. Both studies focus on protein biomarkers in thoracic transplantation. First, the editors speak with Tereza Martinu, MD, MHS, Assistant Professor and Clinician at Toronto General Hospital. Dr. Martinu is the lead author on a paper entitled “Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.” Beginning at 1:45, Erika Lease, MD, and David Schibilsky, MD, interview Dr. Martinu about the findings of the study and potential future application in clinical settings. Starting at 13:35, Van-Khue Ton, MD, PhD, and Marty Tam, MD, are in conversation with Lauren Truby, MD, Cardiology Fellow at Duke University Medical Center, about her study from the December issue: “Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.” Dr. Truby discusses her team’s work on PGD, the expression of CLEC4C in transplant patients, and future potential work in the field. Follow along in the December issue at www.jhltonline.org/current, or, if you’re an ISHLT member, log in at ishlt.org/journal-of-heart-lung-transplantation.  Don’t already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org. This episode of JHLT: The Podcast, but not the studies within, is sponsored by Paragonix.